Amgen Inc (XTER:AMG)
€ 265.4 15.2 (6.08%) Market Cap: 143.51 Bil Enterprise Value: 192.49 Bil PE Ratio: 35.86 PB Ratio: 20.00 GF Score: 88/100

Q3 2024 Amgen Inc Earnings Call Transcript

Oct 30, 2024 / 08:30PM GMT
Release Date Price: €290.7 (-0.68%)
Operator

My name is Julianne, and I will be your conference facilitator today for Amgen's third-quarter 2024 financial results conference call. (Operator Instructions)

I would now like to introduce Justin Claeys, Vice President of Investor Relations. Mr. Claeys, you may now begin.

Justin Claeys Claeys;Robert Bradway
Amgen Inc - Vice President, Investor Relations;Amgen Inc - Chairman of

Thank you, Julianne. Good afternoon, everyone, and welcome to our third quarter 2024 earnings call. Bob Bradway will lead the call and be followed by a broader review of our performance by Murdo Gordon, Vikram Karnani, Jay Bradner, and Peter Griffith.

Through the course of our discussion today, we will use non-GAAP financial measures to describe our performance and have provided appropriate reconciliations within the materials that accompany this call. We will also make some forward-looking statements, which are qualified by our safe harbor statement, and please note that actual results can vary materially.

Over to you, Bob.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot